An update on HAART: part 2
Rosy Weston, MRPharmS, RegPharmNZ, is senior principal pharmacist (HIV and sexual health), Simon Portsmouth, MRCP, MBChB, is consultant physician (HIV and sexual health) and Andrew Benzie, MRCP, MRPharmS, is specialist registrar (HIV and sexual health), all at St Mary’s NHS Trust Hospital, London
Since 1996, the care of individuals living with HIV has been transformed by highly active antiretroviral therapy (HAART), where a combination of three or more antiretrovirals is used as treatment. There are now four classes of antiretrovirals. The introduction of protease inhibitors in 1996 had a dramatic effect on altering morbidity and mortality in HIV-infected individuals.
Full text (PDF, 80K)
Citation: The Pharmaceutical Journal URI: 10018062
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.£35.00Buy now
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now